233. ウォルフラム症候群 Wolfram syndrome Clinical trials / Disease details

臨床試験数 : 11 / 薬物数 : 17 - (DrugBank : 8) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 41

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04940572 (ClinicalTrials.gov)	November 26, 2021	11/5/2021	Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome	AUDIOWOLF: A Phase II, Open-label, Efficacy Study of Daily Administration of Sodium Valproate in Pat ...	Wolfram Syndrome	Drug: Depakine	Centre d'Etude des Cellules Souches	Genethon	Recruiting	13 Years	N/A	All	23	Phase 2	France
2	EUCTR2020-004594-43-FR (EUCTR)		11/03/2021	AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in pat ...	AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in pat ...	Wolfram syndrome MedDRA version: 20.0;Level: PT;Classification code 10078338;Term: Wolfram syndrome; ...	Trade Name: DEPAKINE CHRONO® 500 mg Product Name: DEPAKINE CHRONO 500 mg	CECS/I-Stem	NULL	NA			Female: yes Male: yes	23	Phase 2	France

First Previous1Next Last